APLE is a 216-hotel, upscale rooms-focused REIT operating across 37 states and 83 markets, using portfolio scale, branded select-service hotels and low leverage to pursue steady hotel cash flow and selective acquisitions. This filing mostly repackages the existing operating story rather than changing it. The presentation highlights Q2 comparable RevPAR growth of 5.3%, a 120-basis-point EBITDA margin expansion and July RevPAR growth of more than 6%, but those figures were already part of the company’s Q2 reporting cycle. 〔0〕 〔1〕 〔2〕
| Metric | Q2 2026 | Comparison |
|---|---|---|
| Comparable Hotels RevPAR | $136.17 | +5.3% year over year |
| Comparable Hotels Adjusted Hotel EBITDA | $153.4M | +9.7% year over year |
| Comparable Hotels EBITDA margin | 38.1% | +120 bps year over year |
| MFFO per share | $0.52 | +8.3% year over year |
| July comparable RevPAR | — | More than 6% year-over-year growth |
The presentation does not establish a new earnings or guidance benchmark. It contains no revised outlook, dividend change, financing action or completed transaction; the filing simply furnishes an updated conference presentation under Regulation FD. The supplied exhibit also does not provide a clear, standalone August or September operating figure despite the cover description saying it contains such statistics.
The acquisition pipeline remains optionality, not current growth. APLE shows 557 rooms under development in Anchorage and Las Vegas for a combined anticipated purchase price of $209.2 million, with expected completion in the fourth quarter of 2027 and second quarter of 2028. Those projects remain subject to closing conditions and therefore do not yet change reported operations or near-term cash flow. 〔3〕
Bottom line: This is a confirmation document, not a new business event. APLE’s hotel momentum and balance-sheet flexibility remain intact, but the filing adds too little incremental information to alter the standing story or support a beat-or-miss read.
Read the original 8-K on SEC EDGAR ↗